Asia-Pacific ion chromatography mass spectrometry market is projected to register a substantial CAGR in the forecast period of 2020 to 2027. The new market report contains data for historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation:
By Type (Systems, Software), Platform (Hybrid Mass Spectrometry, Single Mass Spectrometry, Other Platforms), Mode Of Operation {(Single Ion Monitoring (SIM), Selected Reaction Monitoring (SRM), High Resolution Accurate Mass (HRAM)}, Work Flow (Electrospray Ionization (ESI), Atmospheric Pressure Chemical Ionization (APCI), Others), End User (Biotechnology Companies, Pharmaceutical Companies, Food and Beverage Companies, Contract Research Organizations, Diagnostic Centers, Forensic Laboratories, Hospitals, Academic and Research Institutes, Others), Distribution Channel (Direct Tender, Retail Sales), Country (China, Japan, South Korea, India, Thailand, Malaysia, Australia, Indonesia, Philippines, Vietnam, New Zealand and Rest of Asia-Pacific)
Some of the major factors contributing to the growth of the Asia-Pacific ion chromatography mass spectrometry market:
- Rising demand from emerging countries such as India, China
- Increased pharmaceutical expenditure; supplementing the growth of the market

Market Players:

The key market players for Asia-Pacific ion chromatography mass spectrometry market are listed below:

- Thermo Fisher Scientific Inc.
- Waters Corporation
- Intertek Group plc
- Arc Trinova Ltd
- MOBILion Systems, Inc
- Agilent Technologies, Inc.
- Metrohm AG
- JASCO
- Rigaku Corporation
- JEOL Ltd.
- IONTOF GmbH
- LECO Corporation
- Extrel CMS, LLC
- MassTech
- AMETEK.Inc.
- Shimadzu Corporation
- SCIEX
- PerkinElmer Inc.
- Bruker